Cargando…

Pathological manifestations in lymphatic filariasis correlate with lack of inhibitory properties of IgG4 antibodies on IgE-activated granulocytes

Helminth parasites are known to be efficient modulators of their host’s immune system. To guarantee their own survival, they induce alongside the classical Th2 a strong regulatory response with high levels of anti-inflammatory cytokines and elevated plasma levels of IgG4. This particular antibody wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Prodjinotho, Ulrich F., von Horn, Charlotte, Debrah, Alex Y., Batsa Debrah, Linda, Albers, Anna, Layland, Laura E., Hoerauf, Achim, Adjobimey, Tomabu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542694/
https://www.ncbi.nlm.nih.gov/pubmed/28742098
http://dx.doi.org/10.1371/journal.pntd.0005777
_version_ 1783255038957715456
author Prodjinotho, Ulrich F.
von Horn, Charlotte
Debrah, Alex Y.
Batsa Debrah, Linda
Albers, Anna
Layland, Laura E.
Hoerauf, Achim
Adjobimey, Tomabu
author_facet Prodjinotho, Ulrich F.
von Horn, Charlotte
Debrah, Alex Y.
Batsa Debrah, Linda
Albers, Anna
Layland, Laura E.
Hoerauf, Achim
Adjobimey, Tomabu
author_sort Prodjinotho, Ulrich F.
collection PubMed
description Helminth parasites are known to be efficient modulators of their host’s immune system. To guarantee their own survival, they induce alongside the classical Th2 a strong regulatory response with high levels of anti-inflammatory cytokines and elevated plasma levels of IgG4. This particular antibody was shown in different models to exhibit immunosuppressive properties. How IgG4 affects the etiopathology of lymphatic filariasis (LF) is however not well characterized. Here we investigate the impact of plasma and affinity-purified IgG/IgG4 fractions from endemic normals (EN) and LF infected pathology patients (CP), asymptomatic microfilaraemic (Mf+) and amicrofilaraemic (Mf-) individuals on IgE/IL3 activated granulocytes. The activation and degranulation states were investigated by monitoring the expression of CD63/HLADR and the release of granule contents (neutrophil elastase (NE), eosinophil cationic protein (ECP) and histamine) respectively by flow cytometry and ELISA. We could show that the activation of granulocytes was inhibited in the presence of plasma from EN and Mf+ individuals whereas those of Mf- and CP presented no effect. This inhibitory capacity was impaired upon depletion of IgG in Mf+ individuals but persisted in IgG-depleted plasma from EN, where it strongly correlated with the expression of IgA. In addition, IgA-depleted fractions failed to suppress granulocyte activation. Strikingly, affinity-purified IgG4 antibodies from EN, Mf+ and Mf- individuals bound granulocytes and inhibited activation and the release of ECP, NE and histamine. In contrast, IgG4 from CP could not bind granulocytes and presented no suppressive capacity. Reduction of both the affinity to, and the suppressive properties of anti-inflammatory IgG4 on granulocytes was reached only when FcγRI and II were blocked simultaneously. These data indicate that IgG4 antibodies from Mf+, Mf- and EN, in contrast to those of CP, natively exhibit FcγRI/II-dependent suppressive properties on granulocytes. Our findings suggest that quantitative and qualitative alterations in IgG4 molecules are associated with the different clinical phenotypes in LF endemic regions.
format Online
Article
Text
id pubmed-5542694
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-55426942017-08-12 Pathological manifestations in lymphatic filariasis correlate with lack of inhibitory properties of IgG4 antibodies on IgE-activated granulocytes Prodjinotho, Ulrich F. von Horn, Charlotte Debrah, Alex Y. Batsa Debrah, Linda Albers, Anna Layland, Laura E. Hoerauf, Achim Adjobimey, Tomabu PLoS Negl Trop Dis Research Article Helminth parasites are known to be efficient modulators of their host’s immune system. To guarantee their own survival, they induce alongside the classical Th2 a strong regulatory response with high levels of anti-inflammatory cytokines and elevated plasma levels of IgG4. This particular antibody was shown in different models to exhibit immunosuppressive properties. How IgG4 affects the etiopathology of lymphatic filariasis (LF) is however not well characterized. Here we investigate the impact of plasma and affinity-purified IgG/IgG4 fractions from endemic normals (EN) and LF infected pathology patients (CP), asymptomatic microfilaraemic (Mf+) and amicrofilaraemic (Mf-) individuals on IgE/IL3 activated granulocytes. The activation and degranulation states were investigated by monitoring the expression of CD63/HLADR and the release of granule contents (neutrophil elastase (NE), eosinophil cationic protein (ECP) and histamine) respectively by flow cytometry and ELISA. We could show that the activation of granulocytes was inhibited in the presence of plasma from EN and Mf+ individuals whereas those of Mf- and CP presented no effect. This inhibitory capacity was impaired upon depletion of IgG in Mf+ individuals but persisted in IgG-depleted plasma from EN, where it strongly correlated with the expression of IgA. In addition, IgA-depleted fractions failed to suppress granulocyte activation. Strikingly, affinity-purified IgG4 antibodies from EN, Mf+ and Mf- individuals bound granulocytes and inhibited activation and the release of ECP, NE and histamine. In contrast, IgG4 from CP could not bind granulocytes and presented no suppressive capacity. Reduction of both the affinity to, and the suppressive properties of anti-inflammatory IgG4 on granulocytes was reached only when FcγRI and II were blocked simultaneously. These data indicate that IgG4 antibodies from Mf+, Mf- and EN, in contrast to those of CP, natively exhibit FcγRI/II-dependent suppressive properties on granulocytes. Our findings suggest that quantitative and qualitative alterations in IgG4 molecules are associated with the different clinical phenotypes in LF endemic regions. Public Library of Science 2017-07-24 /pmc/articles/PMC5542694/ /pubmed/28742098 http://dx.doi.org/10.1371/journal.pntd.0005777 Text en © 2017 Prodjinotho et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Prodjinotho, Ulrich F.
von Horn, Charlotte
Debrah, Alex Y.
Batsa Debrah, Linda
Albers, Anna
Layland, Laura E.
Hoerauf, Achim
Adjobimey, Tomabu
Pathological manifestations in lymphatic filariasis correlate with lack of inhibitory properties of IgG4 antibodies on IgE-activated granulocytes
title Pathological manifestations in lymphatic filariasis correlate with lack of inhibitory properties of IgG4 antibodies on IgE-activated granulocytes
title_full Pathological manifestations in lymphatic filariasis correlate with lack of inhibitory properties of IgG4 antibodies on IgE-activated granulocytes
title_fullStr Pathological manifestations in lymphatic filariasis correlate with lack of inhibitory properties of IgG4 antibodies on IgE-activated granulocytes
title_full_unstemmed Pathological manifestations in lymphatic filariasis correlate with lack of inhibitory properties of IgG4 antibodies on IgE-activated granulocytes
title_short Pathological manifestations in lymphatic filariasis correlate with lack of inhibitory properties of IgG4 antibodies on IgE-activated granulocytes
title_sort pathological manifestations in lymphatic filariasis correlate with lack of inhibitory properties of igg4 antibodies on ige-activated granulocytes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542694/
https://www.ncbi.nlm.nih.gov/pubmed/28742098
http://dx.doi.org/10.1371/journal.pntd.0005777
work_keys_str_mv AT prodjinothoulrichf pathologicalmanifestationsinlymphaticfilariasiscorrelatewithlackofinhibitorypropertiesofigg4antibodiesonigeactivatedgranulocytes
AT vonhorncharlotte pathologicalmanifestationsinlymphaticfilariasiscorrelatewithlackofinhibitorypropertiesofigg4antibodiesonigeactivatedgranulocytes
AT debrahalexy pathologicalmanifestationsinlymphaticfilariasiscorrelatewithlackofinhibitorypropertiesofigg4antibodiesonigeactivatedgranulocytes
AT batsadebrahlinda pathologicalmanifestationsinlymphaticfilariasiscorrelatewithlackofinhibitorypropertiesofigg4antibodiesonigeactivatedgranulocytes
AT albersanna pathologicalmanifestationsinlymphaticfilariasiscorrelatewithlackofinhibitorypropertiesofigg4antibodiesonigeactivatedgranulocytes
AT laylandlaurae pathologicalmanifestationsinlymphaticfilariasiscorrelatewithlackofinhibitorypropertiesofigg4antibodiesonigeactivatedgranulocytes
AT hoeraufachim pathologicalmanifestationsinlymphaticfilariasiscorrelatewithlackofinhibitorypropertiesofigg4antibodiesonigeactivatedgranulocytes
AT adjobimeytomabu pathologicalmanifestationsinlymphaticfilariasiscorrelatewithlackofinhibitorypropertiesofigg4antibodiesonigeactivatedgranulocytes